Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06104969 · ClinicalTrials.gov registry record
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
A clinical trial of Diabetes and Diabetic Foot Ulcer, sponsored by University of Michigan.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 8
- Study locations
NCT06104969: Recruiting study of Diabetes and Diabetic Foot Ulcer, sponsored by University of Michigan.
NCT06104969 is a study of Diabetes and Diabetic Foot Ulcer that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 5,000 participants, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06104969, a study of Diabetes and Diabetic Foot Ulcer, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions
Primary Outcome
Proportion of participants with complete wound healing by week 52, defined as complete wound closure where there is skin re-epithelialization without drainage or dressing requirements at two consecutive study visits 2 weeks apart.
Conditions Studied
Study Locations (8)
California
- University of Southern California - Los Angeles
- University of California - San Francisco - San Francisco
Arizona
- University of Arizona College of Medicine - Tucson
Georgia
- Emory University School of Medicine - Atlanta
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- University of Michigan - Ann Arbor
New York
- Northwell Health - Lake Success
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2028-06-15 |
What NCT06104969 shows while recruiting
NCT06104969 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher).
The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT06104969 lists 8 locations in 7 states (California, Arizona, Georgia).
Frequently Asked Questions
What is clinical trial NCT06104969 about?
NCT06104969 is a clinical study titled "DFC 004 Biomarkers for Active Diabetic Foot Ulcers". This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinic...
What is the current status of trial NCT06104969?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-06-15. Estimated completion is 2028-06-15.
What conditions does trial NCT06104969 study?
This clinical trial studies the following conditions: Diabetes, Diabetic Foot Ulcer, Diabetic Foot.
Who is sponsoring clinical trial NCT06104969?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06104969 being conducted?
This trial has 8 study locations across Arizona, California, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06104969's enrollment target sits among peer trials
5,000 14th of 338 higher than 323 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
ECHO Diabetes FQHC
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI